Regeneron Pharmaceuticals Inc
- Board oversight
- Paris Agreement alignment
- Direct lobbying governance
- Regular monitoring cycle
Regeneron indicates that it participates in trade association policy discussions, noting that "Regeneron has a representative on the trade association committee responsible for climate policy and engages actively in association policy deliberations to the extent they occur within the association." However, the company does not disclose any formal governance process for aligning either its direct or indirect lobbying with its climate strategy, including any periodic review or board-level sign-off, and it does not identify a specific individual or internal body to oversee such activities. The absence of a public commitment or position to conduct engagement in line with the goals of the Paris Agreement is made clear by the statement, "No, and we do not plan to have one in the next two years," and we found no evidence of a broader policy or monitoring mechanism for climate lobbying alignment.
This assessment is part of the Lobbying Governance Index, covering 8,500 companies scored on whether they have processes to oversee their climate lobbying. See all companies in North America or all companies in United States.